🇺🇸 FDA
Patent

US 6211165

Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

expired A61KA61K31/00A61K31/7076

Quick answer

US patent 6211165 (Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
60
CPC classes
A61K, A61K31/00, A61K31/7076, A61K45/06, A61K47/55